www.fdanews.com/articles/156816-aurobindo-natco-pharma-get-fda-nod-for-migraine-drug
Aurobindo, Natco Pharma Get FDA Nod for Migraine Drug
July 2, 2013
Aurobindo has received FDA clearance to market its oral rizatriptin benzoate migraine drug for both children and adults.
Business Standard
Business Standard